The 
Introduction
The use of subcutaneous fluid as a method of rehydration is an option sometimes overlooked but worth considering in elderly stroke patients. Such patients often need a period of parenteral hydration because of impaired conscious level and/or dysphagia. Infusion of fluids through the subcutaneous route was first used in paediatric practice in the 1940s.' The method declined in popularity in the 1950s owing to reports of shock caused by osmotic shifts when large amounts of electrolytefree solution were used. 2 In elderly stroke patients, subcutaneous fluids have a number of potential advantages over intravenous.3-7 By sparing the limbs, they offer less hindrance to rehabilitation, and the use of overnight infusions leaves the patient freer to mobilise during the day. As subcutaneous fluids can be started by nursing rather than medical staff, they may allow the more efficient use of human resources. On the other hand, the difficulties and complications of cannulating fragile, elderly veins are well known. 4 Over the last decade, the safety and effectiveness of subcutaneous fluids in the non-emergency situation have been highlighted and, in our unit, subcutaneous fluids are being increasingly used for the hydration of elderly stroke patients. In a recent study of healthy volunteers, the absorption of Correspondence: Y.C. Challiner, M.A., M.R.C.P. Accepted: 9 Subcutaneous fluids were delivered through a 19 gauge 'butterfly' cannula sited by a nurse on the trunk, axillary, scapular or thigh areas. The 'butterfly' cannulae were changed every 48 hours. As far as possible, medical and nursing staff ensured the fluids ran to time. Hyaluronidase was not used routinely but if the subcutaneous infusion ran behind time, 1,500 units of hyaluronidase were added to each litre bag of fluid.
Cost of evaluation of total staff time proved impractical, but we did record the numbers, and calculate the cost of the 'Venflon' and butterfly cannulae used. Any complications of the fluid therapy were noted. The study was approved by the Portsmouth and South East Hampshire Health Authority Ethical Committee.
Results
Seventeen patients received intravenous fluids (i.v.) (age range 71-95, mean age 84.2; 11 female) and 17 received subcutaneous (s.c.) fluids (age range 69-93, mean age 82.8; 11 female). Not included in the analysis are two patients allocated to the subcutaneous group who dropped out of the study on Day 2: one died and one developed local oedema.
Both treatments reduced plasma osmolality (Figures 1 and 2 between the osmolalities of the two treatment groups was found (P = 0.12). The least squares estimate of the difference between the i.v. and s.c. groups, given the Day 1 value was estimated to be 5.44 mOsm/kg (95% confidence interval -1.38 to 12.25). There were two minor local reactions in the s.c. group (erythema) and one in the i.v. (bruising). One patient in the s.c. group required hyaluronidase owing to poor absorption. On Day 3 there were two cases ofclinically significant hyponatraemia (taken as serum sodium of 130 or less) in the s.c. group and four in the i.v., although this difference was not statistically significant (Fisher's exact test; P = 0.66). In these instances the fluid regime was stopped or changed as appropriate. 
The total cost of the cannulae used during the three days of the study was £4.93 for subcutaneous therapy and £13.94 for intravenous. No problems with venous access were recorded.
Discussion
This study found no statistical difference in the abilities of subcutaneous and intravenous fluids to restore biochemical hydration in elderly, acute stroke patients. The subcutaneous infusion of fluids has a number of potential advantages over the intravenous route, including simplicity of administration, cost effectiveness and possibly fewer serious complications. We would recommend its consideration as an alternative form of hydration in elderly stroke patients.
The complication rate in each group was minor. Hyponatraemia was the most frequent complication in the intravenous group. A likely contributing factor in both groups was the tendency of stroke to cause syndrome of inappropriate anti-diuretic hormone (SIADH). Factors governing fluid and electrolyte balance in the elderly are complex.'0 Although for the purposes ofthis study, all patients received the same fluid regime, we would agree with the view of O'Neill et al. that a standard regime may not be appropriate for all patients and that, ideally, frequent biochemical measurements would be used to tailor fluid therapy to individual needs. " Our study looked only at biochemical markers of hydration. Clinical markers of hydration, such as postural hypotension, were not measured and it cannot be assumed that biochemical results would necessarily correlate with clinical impression.
Potentially, subcutaneous fluid therapy could save resources in terms of medical staff time. An analysis of the cost of staff time was beyond the scope of this study. However, we did find significant savings in the cost of the cannulae for subcutaneous therapy. It is possible that the calculated cost of intravenous cannulae used is an underestimate, as junior doctors may not have recorded 'failed attempts'. 
